Brief: Passage Bio To Showcase GM1 Gangliosidosis And Krabbe Clinical Programs

Passage Bio

31/01/2022 12:04

Jan 31 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO TO SHOWCASE GM1 GANGLIOSIDOSIS AND KRABBE
CLINICAL
PROGRAMS AT 2022 WORLDSYMPOSIUM, FEBRUARY 7 - 11

Source text for Eikon:  ID:nGNXjSrNy 
Further company coverage:  PASG.O 

 ((Reuters.Briefs@thomsonreuters.com;))